These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 38383747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z, Lu C, Lu B, Gao H, Liang R, Xiang W.
    BMC Genomics; 2023 Mar 29; 24(1):162. PubMed ID: 36991314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.
    Wang Y, Xu M, Yang Q.
    Curr Probl Cancer; 2019 Apr 29; 43(2):167-176. PubMed ID: 29567372
    [Abstract] [Full Text] [Related]

  • 11. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Lu X, Jing L, Liu S, Wang H, Chen B.
    Int J Endocrinol; 2022 Apr 29; 2022():5006123. PubMed ID: 35719192
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H.
    Dis Markers; 2018 Apr 29; 2018():5468672. PubMed ID: 30026881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X, Chen Y, Zhu X, Gong Z, Yu F, Zhang P, Song Y, Li H.
    Asian Pac J Cancer Prev; 2023 Apr 01; 24(4):1275-1287. PubMed ID: 37116150
    [Abstract] [Full Text] [Related]

  • 17. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J, Wang W, Song B, Song Y, Meng Z.
    Biomed Res Int; 2020 Apr 01; 2020():2837906. PubMed ID: 32802839
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial Carcinoma.
    Jiang XY, Hu JJ, Wang R, Zhang WY, Jin QQ, Yang YT, Mei J, Hong L, Yao H, Tao F, Li JJ, Liu Y, Zhang L, Chen SX, Chen G, Song Y, Zhou SG.
    Biochem Genet; 2024 Oct 01; 62(5):3439-3466. PubMed ID: 38108937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.